Gary S. Hoffman mostly deals with Surgery, Internal medicine, Vasculitis, Gastroenterology and Systemic disease. His Surgery research includes elements of Wegener s, Pharmacotherapy and Giant cell arteritis. His Vasculitis study combines topics from a wide range of disciplines, such as Exacerbation, Immunology, Asymptomatic, Matrigel and Cohort.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Infliximab and Chemotherapy. His Systemic disease study integrates concerns from other disciplines, such as Bladder cancer, Urinary bladder, Vascular disease and Cystoscopy. Gary S. Hoffman studied Prednisone and Granulomatosis with polyangiitis that intersect with Family medicine and Rheumatism.
His main research concerns Vasculitis, Internal medicine, Immunology, Pathology and Surgery. He interconnects Systemic disease and Dermatology in the investigation of issues within Vasculitis. His biological study spans a wide range of topics, including Gastroenterology and Rituximab.
Gary S. Hoffman works mostly in the field of Immunology, limiting it down to concerns involving Anti-neutrophil cytoplasmic antibody and, occasionally, Proteinase 3. Gary S. Hoffman is interested in Prednisone, which is a field of Surgery. His Granulomatosis with polyangiitis research is multidisciplinary, relying on both Microscopic polyangiitis and Eosinophilic.
His scientific interests lie mostly in Vasculitis, Internal medicine, Granulomatosis with polyangiitis, Immunology and Gastroenterology. His Vasculitis research is multidisciplinary, incorporating perspectives in Maintenance therapy and Rituximab. His work in the fields of Azathioprine, Cohort, Birmingham Vasculitis Activity Score and Retrospective cohort study overlaps with other areas such as Univariate analysis.
His Granulomatosis with polyangiitis research integrates issues from Surgery, Microscopic polyangiitis, Eosinophilic, Etanercept and Craniofacial. His studies deal with areas such as Biomarker, Genetics and Genome-wide association study as well as Immunology. His research in Gastroenterology intersects with topics in Urinary system, Systemic vasculitis and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu.
Arthritis & Rheumatism (2013)
Wegener granulomatosis : an analysis of 158 patients
Gary S. Hoffman;Gail S. Kerr;Randi Y. Leavitt;Claire W. Hallahan.
Annals of Internal Medicine (1992)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo.
The New England Journal of Medicine (2010)
Revised international Chapel Hill consensus conference nomenclature of vasculitides
J. C. Jennette;R. J. Falk;P. Bacon;N Basu.
Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis
Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera.
The New England Journal of Medicine (2013)
Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis
C Talar-Williams;Y M Hijazi;M M Walther;W M Linehan.
Annals of Internal Medicine (1996)
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.
Hannelore Ehrenreich;Robert W. Anderson;Cecil H. Fox;Peter Rieckmann.
Journal of Experimental Medicine (1990)
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin.
Arthritis & Rheumatism (2002)
Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis: A Randomized Trial
Gary S. Hoffman;Maria C. Cid;Karen E. Rendt-Zagar;Peter A. Merkel.
Annals of Internal Medicine (2007)
Antineutrophil cytoplasmic antibodies
Gary S. Hoffman;Ulrich Specks.
Arthritis & Rheumatism (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: